![System.Func`1[System.String]](/siteassets/images/z-mckesson-logosicons/health-systems2.png)
Our Specialty Pharmacy Enablement (SPE) expert discusses 3 critical areas of access for the health system specialty pharmacy.
Considerations for Integrating Cell & Gene Therapies into Community Hospitals
Insights on expanding access to CGT treatments within community healthcare systems.
By
Date
June 05, 2024
Read time: 4 minutes
By: Joe DePinto
The second of a two-part article recently published by Cell & Gene and coauthored by Joe DePinto, Head of Cell, Gene, & Advanced Therapies at McKesson, emphasizes the need to deliver the right treatments at the right time and place. The article explores strategies for integrating cell and gene therapies (CGTs) into community hospitals, considering factors like geographic location, patient access, and clinical outcomes. Operational challenges and financial implications of bringing CGTs to community settings – including infrastructure, training, and reimbursement issues – are also discussed. Read the full article, Part 2: Getting The System Ready: Enabling Investment In Community Hospitals To Improve Patient Access To Cell And Gene Therapies, on Cell & Gene.
Subscribe Now
To learn how McKesson can help health systems achieve more, sign up to have the Prescribed Perspectives newsletter delivered directly to your inbox.
Related Stories
The most downloaded content by health system pharmacy leaders in August 2025.
With available labor resources dwindling and a shrinking pipeline, health systems must find creative solutions for better using the personnel and partnerships they have.
As payer dynamics shift, therapy pipelines grow, and leakage accelerates, health systems leaders should rethink what infusion care can and should be.
At this year's event, our experts heard from health systems who may be underutilizing available tools and resources in 340B program management.
Click through this interactive experience for a closer look at what you can expect at this year’s HealthTrust University Conference.
Our experts continue shaping industry conversations through regular conference and event engagements, like the HealthTrust University 340B Summit.
The most downloaded content by health system pharmacy leaders in July 2025.
McKesson’s Head of Cell, Gene, and Advanced Therapies discusses opportunities and challenges with CGT in the health system.
This interactive experience highlights key aspects of our SPE solutions, designed to help your health system achieve more.